Top Suppliers:I want be here

1042385-75-0

1042385-75-0 structure
1042385-75-0 structure
  • Name: PF-00299804
  • Chemical Name: (E)-N-[4-(3-chloro-4-fluoroanilino)-7-methoxyquinazolin-6-yl]-4-piperidin-1-ylbut-2-enamide,hydrate
  • CAS Number: 1042385-75-0
  • Molecular Formula: C24H27ClFN5O3
  • Molecular Weight: 487.95
  • Catalog: Signaling Pathways JAK/STAT Signaling EGFR
  • Create Date: 2017-06-19 08:42:18
  • Modify Date: 2026-07-01 14:56:44
  • Dacomitinib (PF-00299804) hydrate is an orally active, irreversible pan-ErbB inhibitor. Dacomitinib hydrate can be used in the research of cancers such as metastatic non-small cell lung cancer (NSCLC)[1].

Name (E)-N-[4-(3-chloro-4-fluoroanilino)-7-methoxyquinazolin-6-yl]-4-piperidin-1-ylbut-2-enamide,hydrate
Synonyms Dacotinib monohydrate
PF-00299804-3
Dacomitinib (PF-00299804) Hydrate
Dacomitinib Monhydrate
(2E)-N-[4-[(3-Chloro-4-fluorophenyl)amino]-7-methoxy-6-quinazolinyl]-4-(1-piperidinyl)-2-butenamide hydrate (1:1)
PF-00299804 hydrate
2-Butenamide,N-(4-((3-chloro-4-fluorophenyl)amino)-7-methoxy-6-quinazolinyl)-4-(1-piperidinyl)-,hydrate (1:1),(2E)
PF-804
Dacomitinib
dacomitinib hydrate
Dacomitinib hydrate (JAN)
Dacomitinib hydrate, 10 mM in DMSO
DACOMITINIB MONHYDRAT
(2E)-N-[4-[(3-chloro-4-fluorophenyl)amino]-7-methoxy-6-quinazolinyl]-4-(1-piperidinyl)-2-butenamide, hydrate (1:1)
UNII-5092U85G58
Dacomitinib hydrate (PF-00299804
Dacomitinib monohydrate
Dacomitinib hydrate
(2E)-N-(4-(3-Chloro-4-fluorophenyl)amino)7-methoxyquinazolin-6-yl)4-(piperidin-1-yl)but-2-enamide monohydrate
(2E)-N-{4-[(3-Chloro-4-fluorophenyl)amino]-7-methoxy-6-quinazolinyl}-4-(1-piperidinyl)-2-butenamide hydrate (1:1)
Dacomitinib [USAN:INN]
PF-299804 hydrate
2-Butenamide, N-[4-[(3-chloro-4-fluorophenyl)amino]-7-methoxy-6-quinazolinyl]-4-(1-piperidinyl)-, (2E)-, hydrate (1:1)
PF-00299804 dacomitinib
(2E)-N-{4-[(3-chloro-4-fluorophenyl)amino]-7-methoxyquinazolin-6-yl}-4-(piperidin-1-yl)but-2-enamide monohydrate
Description Dacomitinib (PF-00299804) hydrate is an orally active, irreversible pan-ErbB inhibitor. Dacomitinib hydrate can be used in the research of cancers such as metastatic non-small cell lung cancer (NSCLC)[1].
Related Catalog
References

[1]. Lau SCM, et al. Dacomitinib in the Management of Advanced Non-Small-Cell Lung Cancer. Drugs. 2019 Jun;79(8):823-831.  

Molecular Formula C24H27ClFN5O3
Molecular Weight 487.95
Exact Mass 487.178650
PSA 92.10000
LogP 5.75120
Hazard Codes Xi
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.